|
|
|
|
|
|
|
|
|
28.01.26 - 12:36
|
Elevance Health Inc. Profit Climbs In Q4 (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Elevance Health Inc. (ELV) revealed earnings for its fourth quarter that Increases, from last yearThe company's bottom line came in at $547 million, or $2.47 per share. This......
|
|
|
|
|
|
|
28.01.26 - 12:06
|
Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook (Business Wire)
|
|
|
4Q 2025 operating revenue of $49.3 billion; FY 2025 of $197.6 billion
4Q 2025 diluted EPS1 of $2.47; adjusted diluted EPS2 of $3.33
FY 2025 diluted EPS1 of $25.21; adjusted diluted EPS2 of $30.29
Projected FY 2026 GAAP diluted EPS1 to be at least $22.30
Projected FY 2026 adjusted diluted EPS2 to be at least $25.50
Returned $4.1 billion of capital to shareholders in 2025
Reaffirming long-term earnings algorithm; recalibrating segment margin targets
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2025 results.
"Elevance Health delivered fourth quarter results in line with our outlook, reflecting disciplined execution in a dynamic environment. As we enter 2026, our focus is on advancing affordability and making healthcare easier to access and navigate for the members we serve. Through pricing discipline and targeted investments, we are strengthening the earnings power of our diversified platform and remain confident in our ability to return to at le...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22.12.25 - 22:36
|
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2025 Results on January 28, 2026 (Business Wire)
|
|
|
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:
888-947-9963 - Access Code - 3972058 (Domestic)
312-470-0178 - Access Code - 3972058 (International)
888-566-0046 - No Access Code (Domestic Replay)
203-369-3677 - No Access Code (International Replay)
The replay will be available from 11:30 a.m. EST on January 28, 2026, until the end of the day on February 27, 2026. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. You may also access the webcast here. A webcast replay will be available following the call.
About Elevance Health
Elevance Health is a lifetime, trusted health partner whose ...
|
|
|
|
|
|
|
10.12.25 - 22:33
|
Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence (Business Wire)
|
|
|
INDIANAPOLIS--(BUSINESS WIRE)--The board of directors of Elevance Health (NYSE: ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, effective January 12, 2026. Schulman will serve on the Audit and Finance Committees, contributing deep expertise in healthcare innovation, regulatory strategy, and value creation across complex, global enterprises.
This appointment reflects Elevance Health's ongoing board refreshment strategy to ensure diverse, independent, and future-focused leadership that aligns with the company's long-term strategy and stakeholders' priorities.
“Amy's record of driving innovation, disciplined investment, and strong governance across the healthcare ecosystem will further strengthen our board's ability to deliver long-term value for shareholders and meaningful outcomes for consumers,” said Ramey Peru, Chair of the Elevance Health Board of Directors. “Her insight into the intersection...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
